论文部分内容阅读
作者试用西沙必利治疗胃食管返流(GER)的支气管哮喘21例,取得良好疗效,报告如下.1.临床资料 共40例均为本院确诊的支气管哮喘合并胃食管返流(GERD)病人,随机分为两组,两组患者年龄、病程、性别及哮喘分型构成比均无统计学差异.其中治疗组21例,在常规解痉、抗炎、祛痰、止咳等常规治疗下加用西沙必利40mg/d;对照组19例,给予常规治疗,另两组均给予氢氧化铝凝胶20ml,餐前及睡前各一次.
The authors trial of cisapride in the treatment of gastroesophageal reflux (GER) bronchial asthma in 21 cases, and achieved good results, the report is as follows.1.A total of 40 cases of clinical data are hospitalized patients with bronchial asthma combined with gastroesophageal reflux (GERD) , Were randomly divided into two groups, the age, course of disease, sex and asthma typing ratio between the two groups were no significant difference in which the treatment group of 21 cases, in the conventional antispasmodic, anti-inflammatory, expectorant, cough and other conventional treatment plus Cisapride 40mg / d; control group 19 cases, given conventional treatment, the other two groups were given aluminum hydroxide gel 20ml, before meals and before going to bed once.